Cell therapy weekly: Stem cells combined with education show promise in patients with autism spectrum disorder

This week: A clinical study has indicated that stem cells may hold potential for severe autism spectrum disorder when combined with educational interventions, Anthony Nolan partners with Medical Technology Innovation Facility to advance cell therapy development and first patient treated with CAR-T immunotherapy manufactured using Lonza Cocoon®. The news highlights: Stem cells combined with education show promise in patients with autism spectrum disorder Anthony Nolan partners with Medical Technology Innovation Facility to advance cell therapy development First patient treated with CAR-T immunotherapy manufactured using Lonza Cocoon® Stem cells combined with education show promise in patients with autism spectrum disorder New...